Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate in Postmenopausal Osteoporosis
NCT02598934Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ibandronate in postmenopausal osteoporosis, sponsored by Roche. Started Aug 2004; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT02598934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598934.